Skip to main navigation
Sangamo Therapeutics, Inc
  • About Us
    • Leadership
    • Contact
  • Technology
    • Genomic Therapies
      • Genome Editing
      • Gene Therapy
      • Cell Therapy
      • Gene Regulation
    • Zinc Finger Platform
    • Presentations
    • Publications
  • Pipeline
    • Proprietary Programs
    • Partnered Programs
  • Patients
    • Hemophilia
    • MPS I + II
    • Patient Stories
      • Stories of MPS
      • Stories of Hemophilia
    • Resources
    • Expanded Access Program
  • Clinical Trials
  • Collaborations
  • Investors + Media
    • Investors + Media
      • Corporate Profile
      • Email Alerts
    • Stock Information
      • Historic Price Lookup
      • Investment Calculator
      • Institutional Ownership
    • News Releases
    • Events + Presentations
    • Financials + SEC Filings
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
      • Financial Fundamentals
        • Trading Statistics
        • Balance Sheet
        • Income Statement
        • Cash Flow
        • Snapshot
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
  • Careers
    • Sangamo Culture
    • Our Values
    • Job Opportunities
  • About Us
    • Leadership
    • Contact
  • Technology
    • Genomic Therapies
      • Genome Editing
      • Gene Therapy
      • Cell Therapy
      • Gene Regulation
    • Zinc Finger Platform
    • Presentations
    • Publications
  • Pipeline
    • Proprietary Programs
    • Partnered Programs
  • Patients
    • Hemophilia
    • MPS I + II
    • Patient Stories
      • Stories of MPS
      • Stories of Hemophilia
    • Resources
    • Expanded Access Program
  • Clinical Trials
  • Collaborations
  • Investors + Media
    • Investors + Media
      • Corporate Profile
      • Email Alerts
    • Stock Information
      • Historic Price Lookup
      • Investment Calculator
      • Institutional Ownership
    • News Releases
    • Events + Presentations
    • Financials + SEC Filings
      • Quarterly Results
      • Analyst Coverage
      • Earnings Estimates
      • Financial Fundamentals
        • Trading Statistics
        • Balance Sheet
        • Income Statement
        • Cash Flow
        • Snapshot
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
  • Careers
    • Sangamo Culture
    • Our Values
    • Job Opportunities

Quarterly Results

  • Investors + Media
    • Corporate Profile
    • Email Alerts
  • Stock Information
    • Historic Price Lookup
    • Investment Calculator
    • Institutional Ownership
  • News Releases
  • Events + Presentations
  • Financials + SEC Filings
    • Quarterly Results
    • Analyst Coverage
    • Earnings Estimates
    • Financial Fundamentals
      • Trading Statistics
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Snapshot
  • Corporate Governance
    • Leadership Team
    • Board of Directors
    • Committee Composition

Quarterly Results

Show all

2018

Q4
  • Release
  • Form 10-K
Q3
  • Release
  • 10-Q
Q2
  • Release
  • 10-Q
Q1
  • Release
  • 10-Q

2017

Q4
  • Release
  • 10-K
Q3
  • Release
  • 10-Q
Q2
  • Release
  • 10-Q
Q1
  • Release
  • 10-Q

2016

Q4
  • Release
  • 10-K
Q3
  • Release
  • 10-Q
Q2
  • Release
  • 10-Q
Q1
  • Release
  • 10-Q
footer-logo

© Sangamo Therapeutics

LinkedIn Twitter Facebook
  • Disclaimer
  • Privacy Policy